China Universal Asset Management »

Sionna Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $423k 10k 41.14
2025-09-30 $147k 5.0k 29.41

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Vanguard Group
Perceptive Advisors
Jennison Associates
Deerfield Management Company
BlackRock
Standard Life Aberdeen
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics